|
|
Article: Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers.
- Article from:
- PR Newswire
- Article date:
- August 20, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
GRAND RAPIDS, Mich., Aug. 20 /PRNewswire/ -- The Center for Molecular Medicine (CMM) today said it was the only lab in the Midwest capable of testing nursing mothers for codeine risks cited in a Friday alert from the U.S. Food and Drug Administration (FDA).
Late Friday, the FDA issued an advisory noting new information about a very rare, but serious, side effect in nursing infants whose mothers are taking codeine and are also ultra-rapid metabolizers of that drug. The FDA advisory recommended physicians order a CYP2D6 genotyping test to determine how the patient will metabolize codeine in advance of its prescription.
The FDA noted that when codeine ...
Related newspaper, magazine, and journal articles:
|
|
Article: Center for Molecular Medicine Among First Labs in ...
PR Newswire;
December 12, 2007 ;
700+ words
...GRAND RAPIDS, Mich., Dec ... The Center for Molecular Medicine (CMM) today ... expanding field of molecular medicine." The CellSearch ... The Center for Molecular Medicine, a joint venture between Grand Rapids, Mich.-based ...
|
|